Ovarian atrophy

What is Ovarian Atrophy?

Ovarian atrophy is an age-related condition in which the ovary loses its normal healthy function. This condition typically happens due to a decrease in the levels of female hormones, estrogen, and progesterone. It can also be caused by some health conditions and treatments, such as chemotherapy or radiation therapy, and can be seen immediately after menopause.

Symptoms of Ovarian Atrophy

The most common symptom of ovarian atrophy is abnormal periods. A woman may have heavy or light periods, as well as more or fewer days of bleeding. Vaginal dryness and pain during intercourse may also occur. Other symptoms may include hot flashes, night sweats, fatigue, and mood changes.

Causes of Ovarian Atrophy

The most common cause of ovarian atrophy is menopause, which occurs when ovary production of estrogen decreases. This can happen in women age 40 and older, or during medical treatments, such as chemotherapy or radiation therapy which can cause the ovaries to stop working. In some cases, ovarian atrophy can also be caused by underlying medical conditions, such as premature ovarian failure.

Risks of Ovarian Atrophy

Ovarian atrophy can increase the risk of some health problems, such as osteoporosis, cardiovascular disease, and diabetes. It can also lead to infertility. It is important to speak with a doctor about any risks of ovarian atrophy.

Treatment of Ovarian Atrophy

Treatment of ovarian atrophy will depend on the underlying cause. Options may include hormone replacement therapy, to help restore hormone levels, as well as certain lifestyle changes and treatments. In some cases, fertility treatments may be used to help restore normal ovary function.

Prevention of Ovarian Atrophy

The best way to protect against ovarian atrophy is to maintain a healthy lifestyle. This includes eating healthy, exercising regularly, reducing stress, getting enough sleep, and staying away from smoking and other unhealthy habits. Women should also speak to a doctor about any underlying medical conditions and the risk of ovarian atrophy.